BDMD

Baird Medical Investment Holdings Ltd Ordinary Share

6.92 USD
-1.93
21.81%
At close Jan 21, 4:00 PM EST
After hours
7.10
+0.18
2.60%
1 day
-21.81%
5 days
-33.33%
1 month
237.56%
3 months
123.23%
6 months
38.40%
Year to date
35.16%
1 year
38.40%
5 years
38.40%
10 years
38.40%
 

About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for BDMD.

Financial journalist opinion

Based on 6 articles about BDMD published over the past 30 days

Neutral
PRNewsWire
16 hours ago
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, proudly announces that Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, has reached a remarkable milestone of successfully completing 100 MWA procedures for thyroid nodules.
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
Neutral
PRNewsWire
4 days ago
Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference
NEW YORK , Jan. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in San Francisco amid the 2025 J.P.
Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference
Neutral
PRNewsWire
1 week ago
Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment
NEW YORK , Jan. 13, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. This program offered physicians practical experience with a state-of-the-art treatment designed to deliver quicker recovery and effective management of thyroid nodules.
Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment
Neutral
PRNewsWire
2 weeks ago
Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
NEW YORK , Jan. 6, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, successfully sponsored and participated in the 4th Sichuan Medical Association Thyroid Disease Academic Conference, held in Sichuan, China. The highly regarded conference gathered top thyroid specialists and healthcare professionals to promote best practices in thyroid disease diagnosis and treatment.
Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
Neutral
PRNewsWire
3 weeks ago
Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leading innovator in minimally invasive microwave ablation (MWA) technology, proudly supported and participated in the 2024 Guangdong Provincial Parathyroid Disease - Southern Yue Forum, held in Guangzhou, China. This distinguished forum, organized by prominent healthcare institutions in Guangdong, brought together esteemed medical experts, researchers, and healthcare professionals to share insights on advancements in the diagnosis and treatment of parathyroid diseases.
Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
Neutral
PRNewsWire
4 weeks ago
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
NEW YORK , Dec. 23, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. The program provided hands-on experience with a cutting-edge treatment that offers patients faster recovery times and effective relief from thyroid nodules.
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
Neutral
PRNewsWire
1 month ago
Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive medical technologies, proudly sponsored and participated in the 2024 Guangdong Thyroid Surgery Committee Annual Meeting in Guangdong, China. The forum, hosted by the Guangdong Provincial Hospital of Traditional Chinese Medicine, brought together experts to advance thyroid disease treatment.
Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
Neutral
PRNewsWire
1 month ago
Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
NEW YORK , Dec. 16, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. The program provided hands-on experience with a cutting-edge treatment that offers patients faster recovery times and effective relief from thyroid nodules.
Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
Neutral
PRNewsWire
1 month ago
Baird Medical Charts 2025 Strategic Vision Following Milestone Year
NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Baird Medical Group (NASDAQ: BDMD), a leader in minimally invasive medical technologies, recently convened its 2024 Annual Review and 2025 Planning Meeting at the Baird Capital Tower in Guangzhou, China. The two-day event brought together executives, production leaders, and regional managers to reflect on the company's achievements and plan for the year ahead.
Baird Medical Charts 2025 Strategic Vision Following Milestone Year
Neutral
PRNewsWire
1 month ago
Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum and Guangdong Pharmaceutical Society Thyroid Specialist Committee Annual Meeting, held in Guangzhou, China. This prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in Guangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases.
Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
Charts implemented using Lightweight Charts™